top of page
Mask group (2).png

Alzheimer's Disease Scientific Exchange Meeting

of Unforgettable Moments
STD Lilly 17.7 (5).png

Diagnosis and treatment of Alzheimer disease
A new treatment area for AD patients

STD Lilly 17.7 (5).png

17/07/24

18:00-21:00

STD Lilly 17.7 (6).png

HaArba'a 28, Tel Aviv

  • Facilitate a comprehensive discussion on the evolving care pathway in early symptomatic Alzheimer‘s Disease, in the era of Amyloid -Targeting Therapies (ATTs)

  • Explore the major advancements in the diagnosis and treatment of patients with initial cognitive decline, and how to incorporate these progresses into clinical practice guidance.

  • Share perspectives and experience on the use of biomarkers for an accurate diagnosis of Alzheimer‘s disease

  • Discuss the most recent data on ATTs and share views on the risk/benefit profile and the clinical meaningfulness of these treatments

Meeting Objectives:

Panelists:

  • Dr Noa Bregman  - Cognitive Neurologist Specialize, The Memory and Attention Disorders Center, Neurology Department, Ichilov hospital – Moderator

  • Dr Rachel Ben Hayun –Cognitive Neurologist Specialize,The Memory problems and ADHD, Rambam hospital

  • Dr Amir Glik - Cognitive Neurologist Specialize, Cognitive Neurology Service, Beilinson - Rabin Medical Center

  • Prof’ Jakob Hort - Jakub Hort, MD, PhD, FEAN, Professor of Neurology, Head of Cognitive Center, Motol University Hospital

Contact
bottom of page